The United States Attorney’s Office for the Middle District of Pennsylvania announced that Dr. Peter J. Baddick III has agreed to pay the United States $60,000 to resolve civil liability for alleged violations of the False Claims Act.

According to the United States Attorney, Gerard M. Karam, between April 2015 and December 2015, Baddick prescribed the opioid medication Subsys to patients who did not have a cancer diagnosis without a legitimate medical purpose outside the usual course of professional practice.

Baddick then billed Medicaid and Tricare for the visits associated with the prescription of Subsys to these patients.

Baddick of Lehighton, operated out of Penn Medical Group which ceased practice in 2019.

A civil action was filed in April of 2022 and is docketed as United States v. Dr. Peter J. Baddick, III.; Civ. No. 3: 22-512.

“This office is dedicated to combatting fraud and abuse impacting taxpayer-funded programs,” said United States Attorney Karam. “We use every tool at our disposal to do so, and this resolution reflects that commitment.”

This Settlement Agreement is neither an admission of liability by Baddick nor a concession by the United States that its claims are not well founded.

This matter was investigated by the U.S. Department of Health and Human Services Office of Inspector General and the Office of the Inspector General for the Defense Health Agency. The investigation was handled by Assistant United States Attorneys, B. Craig Black and Tamara Haken, and the Affirmative Civil Enforcement Unit within the U.S. Attorney’s Office.